Unknown

Dataset Information

0

Stop fRETting the Target: Next-Generation RET Inhibitors Have Arrived.


ABSTRACT: BLU-667 is a next-generation RET inhibitor that maximizes on-target and minimizes off-target effects. It is an exemplar of genotype-driven drug development followed by multi-histology basket trial validation that is becoming a paradigm for precision oncology. Cancer Discov; 8(7); 797-9. ©2018 AACRSee related article by Subbiah et al., p. 836.

SUBMITTER: Iams WT 

PROVIDER: S-EPMC6345252 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Stop fRETting the Target: Next-Generation RET Inhibitors Have Arrived.

Iams Wade T WT   Lovly Christine M CM  

Cancer discovery 20180701 7


<b> BLU-667 is a next-generation RET inhibitor that maximizes on-target and minimizes off-target effects. It is an exemplar of genotype-driven drug development followed by multi-histology basket trial validation that is becoming a paradigm for precision oncology. <i>Cancer Discov; 8(7); 797-9. ©2018 AACR</i><i>See related article by Subbiah et al., p. 836</i>.</b> ...[more]

Similar Datasets

| S-EPMC7486540 | biostudies-literature
| S-EPMC6151281 | biostudies-literature
| S-EPMC4648175 | biostudies-other
| S-EPMC8748217 | biostudies-literature
| S-EPMC8599646 | biostudies-literature
| S-EPMC8454558 | biostudies-literature
2017-04-03 | PXD003804 | Pride
| S-EPMC9218446 | biostudies-literature
| S-EPMC3605921 | biostudies-literature